Percheron Therapeutics LimitedASX: PER

Trial Met Primary & Exceeded Secondary Endpoint Expectations

May 21, 2020 at 1:02 PM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment